News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,605 Results
Type
Article (42235)
Company Profile (463)
Press Release (658907)
Section
Business (208468)
Career Advice (2006)
Deals (35947)
Drug Delivery (92)
Drug Development (83431)
Employer Resources (169)
FDA (16330)
Job Trends (15055)
News (352293)
Policy (33005)
Tag
Academia (2640)
Alliances (50613)
Alzheimer's disease (1306)
Approvals (16250)
Artificial intelligence (135)
Bankruptcy (361)
Best Places to Work (11736)
Biotechnology (349)
Breast cancer (120)
Cancer (1063)
Cardiovascular disease (90)
Career advice (1674)
Cell therapy (236)
Clinical research (65960)
Collaboration (385)
Compensation (190)
COVID-19 (2591)
C-suite (92)
Data (1060)
Diabetes (155)
Diagnostics (6200)
Earnings (86026)
Employer resources (147)
Events (112837)
Executive appointments (285)
FDA (16843)
Funding (344)
Gene therapy (185)
GLP-1 (609)
Government (4412)
Healthcare (19008)
Infectious disease (2673)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16564)
Job creations (3697)
Job search strategy (1431)
Layoffs (439)
Legal (7926)
Lung cancer (168)
Manufacturing (175)
Medical device (13330)
Medtech (13335)
Mergers & acquisitions (19430)
Metabolic disorders (415)
Neuroscience (1578)
NextGen Class of 2024 (6745)
Non-profit (4540)
Northern California (1431)
Obesity (240)
Opinion (197)
Patents (99)
People (57588)
Phase I (20652)
Phase II (29116)
Phase III (21535)
Pipeline (445)
Postmarket research (2600)
Preclinical (8881)
Radiopharmaceuticals (250)
Rare diseases (221)
Real estate (6000)
Regulatory (21958)
Research institute (2417)
Resumes & cover letters (352)
Southern California (1287)
Startups (3749)
United States (13423)
Vaccines (564)
Weight loss (181)
Date
Today (202)
Last 7 days (940)
Last 30 days (3723)
Last 365 days (36575)
2024 (33076)
2023 (41035)
2022 (52312)
2021 (56796)
2020 (54955)
2019 (47474)
2018 (35733)
2017 (33073)
2016 (32428)
2015 (38466)
2014 (32283)
2013 (27219)
2012 (29322)
2011 (29939)
2010 (28074)
Location
Africa (732)
Arizona (198)
Asia (38557)
Australia (6424)
California (3281)
Canada (1257)
China (241)
Colorado (145)
Connecticut (153)
Europe (84154)
Florida (442)
Georgia (112)
Illinois (349)
Indiana (193)
Kansas (99)
Maryland (580)
Massachusetts (2639)
Michigan (155)
Minnesota (274)
New Jersey (939)
New York (940)
North Carolina (747)
Northern California (1431)
Ohio (135)
Pennsylvania (823)
South America (1107)
Southern California (1287)
Texas (449)
Utah (90)
Washington State (365)
701,605 Results for "cognition therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
Cognition Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2024, and provided a business update.
May 7, 2024
·
7 min read
Press Releases
INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
October 28, 2024
·
6 min read
Press Releases
Cognition Therapeutics Will Participate in the Roth Healthcare Opportunities Conference
October 2, 2024
·
5 min read
Press Releases
Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update
November 13, 2024
·
9 min read
Pharm Country
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease
Cognition Therapeutics, Inc provided a recap of the virtual KOL event hosted on April 12, 2024.
April 22, 2024
·
8 min read
Press Releases
Cognition Therapeutics Announces Results of Pre-specified Analysis of SHINE Study Data Presented at CTAD
October 29, 2024
·
10 min read
Pharm Country
Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference - April 02, 2024
Cognition Therapeutics, Inc. announced that the Company’s president and CEO, Lisa Ricciardi, will present at the 23rd Annual Needham Virtual Healthcare Conference taking place April 8-11, 2024.
April 2, 2024
·
5 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
Cognition Therapeutics, Inc. today announced that the Company will release financial results for the fourth quarter and full year ended December 31, 2023 on Tuesday, March 26, 2024 before the market open.
March 15, 2024
·
5 min read
Press Releases
Cognition Therapeutics Presents Poster of Participant Demographics from Phase 2 Dementia with Lewy Bodies Study at CTAD
November 1, 2024
·
8 min read
1 of 70,161
Next
